A
| B
| C
| D
| E
| F
| G
| H
| I
| J
| K
| L
| M
| N
| O
| P
| Q
| R
| S
| T
| U
| V
| W
| X
| Y
| Z
| 0-9
Gratiseintrag
ÜbersichtKurzprofil: Bavarian Nordic is a leading industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need. The company's clinical pipeline targets cancer and infectious diseases, and includes seven development programmes. Two programmes under preparation for Phase 3: PROSTVAC®, a therapeutic vaccine for advanced prostate cancer is being developed under a collaboration agreement with the National Cancer Institute, and IMVAMUNE®, a third-generation smallpox vaccine is being developed under a contract with the US government. Bavarian Nordic is listed on NASDAQ OMX Copenhagen under the symbol BAVA. Dieses Labor ist in folgenden Branchen gelistet:
Dieses Labor hat einen Gratiseintrag geschaltet. Laborprofile mit Komforteintrag
sind wesentlich umfangreicher (siehe Mustereintrag). |
